Home Bistro Retains Baker McKenzie and Donohoe Advisory to Explore an Uplisting
Equifund
Home Bistro is making moves as it explores the potential of uplisting to the Nasdaq.
Menu
Home Bistro is making moves as it explores the potential of uplisting to the Nasdaq.
Here’s a list of the key milestones that need to be achieved to start generating KG™2 Surge™ revenue in 2022.
The last day to invest will be Monday, Nov 15th @ midnight EST.
In this update, Home Bistro announces it has appointed a new CFO and CMO form the Model Meals “Acquihire”.
Kleiner recently attended North American Spine Society (NASS) annual meeting armed with its newly-cleared KG2 device. Here are the highlights…
Home Bistro announces the nationwide launch of Model Meals Brand and partnership with Perfecting Athletes
These two major partnerships will help increase Assure Health’s national exposure.
In our latest addition to Equifund’s CEO Interview Series, we sit down with Fernando Berdegué, CEO of Durango Gold to get an update on the company’s exploration progress, ESG outlook, IPO plans, and more.
Our Equifund-listed medtech deal just got FDA clearance for its next-generation device.
Durango has officially commenced its maiden drill program on the company’s 14,000-acre Claudia Project.
Home Bistro is making moves as it explores the potential of uplisting to the Nasdaq.
Here’s a list of the key milestones that need to be achieved to start generating KG™2 Surge™ revenue in 2022.
The last day to invest will be Monday, Nov 15th @ midnight EST.
In this update, Home Bistro announces it has appointed a new CFO and CMO form the Model Meals “Acquihire”.
Kleiner recently attended North American Spine Society (NASS) annual meeting armed with its newly-cleared KG2 device. Here are the highlights…
Home Bistro announces the nationwide launch of Model Meals Brand and partnership with Perfecting Athletes
These two major partnerships will help increase Assure Health’s national exposure.
In our latest addition to Equifund’s CEO Interview Series, we sit down with Fernando Berdegué, CEO of Durango Gold to get an update on the company’s exploration progress, ESG outlook, IPO plans, and more.
Our Equifund-listed medtech deal just got FDA clearance for its next-generation device.
Durango has officially commenced its maiden drill program on the company’s 14,000-acre Claudia Project.
By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.
Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.
Over 20 patents have been issued to protect the company's technologies.
Just received FDA clearance for their next-generation KG2 spinal fusion technology.
The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO
Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:
We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.
Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.
If you have not received the email in 5 minutes, please click here to have it resent.
Questions? Our customer service team is always here to help – 1-866-338-3004
Thank you for your investment in Home Bistro! To view the status of your investment, click the button below to navigate to your Dashboard.
